Clinical Trial Update: Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating vernakalant versus amiodarone for post-operative atrial fibrillation in cardiac surgery patients; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)
• Vernakalant (vernakalant)

Snippet

Sponsor: University of Calgary | Conditions: Atrial Fibrillation, Post-cardiac Surgery | Phase 3 | Status: NOT_YET_RECRUITING